Pfizer Touts Elrexfio’s Potential For Community Oncology Use In Myeloma

Second Approval Of BCMA-Directed Bispecific Antibody

 
• By Alaric DeArment
  
Pfizer announced the approval of anti-BCMA bispecific antibody Elrexfio for multiple myeloma • Source: Shutterstock

More from New Products

More from Scrip